Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://insight.jci.org/articles/view/129641, but it redirected us to https://insight.jci.org/articles/view/129641. The analysis below is for the second page.

Title[redir]:
JCI Insight - Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Description:
No description found...

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, but we identified it was custom coded using Ruby on Rails (Ruby).

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,420 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

tilb, cells, cancer, breast, cell, til, article, view, pubmed, google, scholar, crossref, tumor, patients, tissues, figure, immune, data, tissue, tls, normal, idc, memory, prognostic, supplemental, tumors, tilhi, ilc, responses, study, tumorinfiltrating, lymphocytes, higher, human, clinical, compared, carcinoma, survival, primary, expression, igg, significant, detected, tilneg, tilint, cytokines, analysis, immunol, increase, tfh,

Topics {✒️}

graphical abstract introduction american society cd3+cd4+cd45+cd200hipd-1hi ihc-stained full-face sections antigen-presenting molecules hla-dr long-term bc-specific survival shorter recurrence-free interval species fluorescence-labeling approach mann-whitney-wilcoxon test shorter recurrence-free survival cd3/cd20 dual staining formalin-fixed paraffin-embedded hiv-infected viremic individuals full-face tissue sections lymphoid tissue development 1 chunyan gu-trantien produce tumor-specific antibodies antigen-driven oligoclonal expansion videos collections cd4/cd8 dual staining long-term clinical outcomes microwave-based antigen retrieval kaplan-meyer survival curves improved disease-free survival node-negative breast cancer cell-mediated antitumor immunity cell–deficient mice suggested triple-negative breast cancer recurrent bc development strong b-cell response methods mol biol cd3–cd19+ lymphocyte gate long-term bc survival cd20+ tumor-infiltrating lymphocytes small-cell lung cancer triple-negative breast cancers cell/pc metagene exhibited transcription factor foxp1 references david tumour-infiltrating cd8+ lymphocytes tumor-infiltrating lymphocyte composition supplemental material node-negative bc patients current data cxcl13-producing tfh current precedent footnotes lb triple-negative bc patients late-stage breast cancer humoral immune system

Questions {❓}

  • Need help?

External Links {🔗}(370)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Tag Manager
  • Google Universal Analytics

Libraries {📚}

  • Foundation
  • Modernizr
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.48s.